AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Compugen Ltd. Regulatory Filings 2004

Mar 2, 2004

6734_rns_2004-03-02_865d0f27-94ed-4a5e-b946-916075d00220.htm

Regulatory Filings

Opens in your device viewer


C002	קומפיוגן בע"מ		2
Public	COMPUGEN LTD.
	2522	Corporation no: 511779639
	Stock Exchange/Market: קומפיוגן

	606
	380	Pinchas Rosen 72 , Tel Aviv 69512 , ,
	Tel: 03-7658585 , 03-7658525 Fax: 03-7658555
	E.mail address: AYALA@COMPUGEN .CO.IL	Date of transmission: 02/03/2004

		Time of broadcast: 13:42 13:39:58
		Reference: 2004-02-074562



Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	6-K regarding: Compugen Discovers Novel Soluble CD40 Protein

CD40 Protein6-k_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):

Previous name of reporting entity:
Date of revision of form structure: 28/12/2003
- - -
Name of the Signatory : Berler-Shapira Ayala Position of Signatory in the reporting corporation: Legal Counsel
Pinchas Rosen Telephone: 03-7658176 , Facsimile: 03-7658516 , E-mail: [email protected]